-transparent.png){kind=logo}
oeurotensin (NT) is a tridecapeptide which is thought to bind to receptors located on dopamine cells in the ventral tegmental area (VTA). Rats with cannulas implanted in the VTA showed a significant increase in time spent in an environment in which they had received bilateral injections of neurotensin on previous days. This is indicative of conditioned reinforcement in which the neuropeptide was the primary reinforcer. In order to determine the specificity of neurotensin receptor interactions, 3 fragments of the peptide were examined at 2 doses. NT1-8 and NT8-13 were found to be inactive while NT1-11 demonstrated significant activity. The results suggest that NT in the VTA is capable of inducing reinforcing effects. This is the first evidence for a non-opiate 'reward peptide'.
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
May 2020,
Neuropharmacology,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
November 1978,
Life sciences,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
October 1973,
The Journal of biological chemistry,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
October 1980,
L'union medicale du Canada,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
November 1976,
The Journal of biological chemistry,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
January 1982,
Annals of the New York Academy of Sciences,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
November 1976,
Chemical & pharmaceutical bulletin,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
December 1976,
Endocrinology,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
December 2010,
Molecular pain,
P W Glimcher, and
D H Margolin, and
A A Giovino, and
B G Hoebel
January 2015,
Frontiers in neuroscience,
